Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.
Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Benavides M, Lotz JP, Misset JL, de Vassal F, Tapiero H, et al.
Machover D, et al. Among authors: goldschmidt e.
Eur J Haematol Suppl. 1987;47:33-42. doi: 10.1111/j.1600-0609.1987.tb00020.x.
Eur J Haematol Suppl. 1987.
PMID: 3471523
No abstract available.